• Skye Bioscience filed an 8-K/A to correct its prior 8-K by disclosing the effective date of its reverse stock split.
• Reverse split takes effect at 12:01 a.m. New York time on Aug. 24, 2026; Nasdaq trading switches to a split-adjusted basis at market open.
• Common stock keeps the SKYE ticker; post-split CUSIP changes to 83086J309.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Skye Bioscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-058120), on August 20, 2026, and is solely responsible for the information contained therein.